Keine Internetverbindung – die gespeicherte Version der Seite wird angezeigt.

CSL Ltd

AUAUD
← Zum Screener
AU:CSLUS:CMXHF

CSL Ltd (AU:CSL) — Biotechnology. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.

Über das Unternehmen

Website
csl.com.au
Investor Relations
investors.csl.com/
Sektor
Healthcare · Biotechnology
Hauptsitz
Melbourne, Australia
CEO
Mr. Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A.
Mitarbeiter
29 000
Gegründet
1994
Ausstehende Aktien
479.88 Mio.
Streubesitz
478.53 Mio.
Marktkapitalisierung
87.08 Mrd. AUD
Insider
0.02%
Institutionelle Anleger
38.27%
Beschreibung

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery; and Alentis Therapeutics AG to develop and commercialise lixudebart for rare kidney and liver diseases. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Börsen und Ticker

BörseTickerWährungPreisTyp
AU Australian Securities ExchangeCSL primärAUD—Stammaktie
US USA StocksCMXHF OTCUSD126.03 -1.29%Stammaktie

Kurs über 3 Monate

Tag mit Kursanstieg Tag mit Kursrückgang Ex-Dividenden-Tag ZahltagTag mit der Maus berühren / antippen — Eröffnungs-, Schluss-, Höchst- und Tiefstkurs

Dividenden

Keine Dividendenzahlungen gefunden (geprüft 08.10.2026). Das Unternehmen schüttet wahrscheinlich keine Dividenden aus.

Neuigkeiten diese Woche

Noch keine Nachrichten von der Website des Unternehmens.

Anzeige

Größte Anteilseigner

InhaberAnteilAktienBerichtsdatum
VANGUARD STAR FUNDS-Vang…1.49%7.16 Mio.2026-07-31
VANGUARD TAX-MANAGED FUN…0.99%4.75 Mio.2026-06-30
iShares Trust-iShares Co…0.75%3.6 Mio.2026-08-31
Fidelity Concord Street…0.39%1.89 Mio.2026-07-31
iShares Trust-iShares MS…0.36%1.72 Mio.2026-08-31
J.P. Morgan Exch-Trd Fd.…0.3%1.45 Mio.2026-07-31
Fidelity Salem Street TR…0.29%1.38 Mio.2026-07-31
iShares Trust-iShares MS…0.28%1.35 Mio.2026-08-31
VANGUARD Intl Eqy. INDEX…0.24%1.16 Mio.2026-07-31
SCHWAB STRATEGIC TRUST-S…0.22%1.08 Mio.2026-05-31
Pacer Advisors, Inc.0.08%369 7742026-06-30
Naylor (Gordon) (Directo…≈0.01%40 8192026-05-26
McKenzie (Paul F) (Chief…≈0.01%31 0532025-09-01
McNamee (Brian Anthony)…≈0.01%30 5612026-08-21
Linton (Joy) (Chief Fina…≈0%15 0962025-06-30
Watkins (Alison Mary) (I…≈0%6 9892026-08-21
Clark (Megan Elizabeth)…≈0%5 7182025-08-22
Schmeltz (Andy) (Other E…≈0%5 0672025-06-30
Hewson (Carolyn Judith)…≈0%4 1312026-08-21
Price (Cameron Bruce) (I…≈0%3 5592026-08-21
Daniels (Brian M.D.) (No…≈0%3 4002025-11-18